Overview
Justin Wray is a Radiation Oncologist in Dallas, Texas. Dr. Wray has been practicing medicine for over 14 years and is rated as an Advanced provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Breast Cancer, Prostate Cancer, Familial Prostate Cancer, and Laryngeal Cancer.
His clinical research consists of co-authoring 11 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article and participated in 1 clinical trial in the study of Prostate Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- PPO
- HMO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- POS
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1441 N. Beckley Avenue, Suite 101, Dallas, TX 75203
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
University Of Texas Southwestern Medical Center At Dallas
Raquibul Hannan is a Radiation Oncologist in Dallas, Texas. Dr. Hannan is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Adult Soft Tissue Sarcoma, Prostatectomy, and Thrombectomy.
University Of Texas Southwestern Medical Center At Dallas
Neil Desai is a Radiation Oncologist in Dallas, Texas. Dr. Desai is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Mycosis Fungoides, and Prostatectomy.
University Of Texas Southwestern Medical Center At Dallas
Aurelie Garant is a Radiation Oncologist in Dallas, Texas. Dr. Garant is rated as an Advanced provider by MediFind in the treatment of Prostate Cancer. Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Esophageal Cancer, and Adult Soft Tissue Sarcoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Wray isAdvanced. Learn about Breast Cancer.
- Familial Prostate CancerDr. Wray isAdvanced. Learn about Familial Prostate Cancer.
- Prostate CancerDr. Wray isAdvanced. Learn about Prostate Cancer.
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer
- Brain TumorDr. Wray isExperienced. Learn about Brain Tumor.
- Cholangiocarcinoma (Bile Duct Cancer)
- EGFR Positive Lung CancerDr. Wray isExperienced. Learn about EGFR Positive Lung Cancer.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- HER-2 Positive Breast CancerDr. Wray isExperienced. Learn about HER-2 Positive Breast Cancer.